Creo Medical Group
CREO · AIM · Health Care · mcap £46m today
All announcements
-
30 Sep 26Unaudited interim results
THIS ANNOUNCEMENT WAS DEEMED BY THE COMPANY TO CONTAIN INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO.
RNS 9797680 ↗ -
28 Jul 26
-
23 Jul 26MicroBlate™ Flex exceeds 100 clinical cases
MicroBlate™ Flex exceeds 100 clinical cases as adoption builds
RNS 9683040 ↗ -
06 Jul 26Award of Shares under Share Incentive Plan
Award of Shares under Share Incentive Plan and Director Dealings
RNS 9654429 ↗ -
29 Jun 26AGM Statement
Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, provides an update to shareholders ahead of its Annual General Meeting ("AGM") being...
RNS 9640289 ↗ -
23 Jun 26Appointment of Nominated Adviser /Corporate Broker
Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, announces the appointment of Shore Capital and Corporate Limited as its Nominated...
RNS 9630755 ↗ -
22 May 26Result of Placing
The Issue Price represents a premium of approximately 31.9 per cent. to the closing middle market price of 11.4 pence per Existing Ordinary Share on 21 May 2026, being the latest practicable date prior to the publication of the Launch Announcement.
RNS 9582454 ↗ -
22 May 26Proposed Placing to raise approximately £5.5m
Creo Medical Group plc (AIM:CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients (the "Company" or "Creo" and, together with its subsidiary undertakings, the "Group"),...
RNS 9581458 ↗ -
22 May 26FY25 Final Results
Strong financial and operational delivery, in-line with market expectations
RNS 9581457 ↗ -
22 May 26Proposed Sale of 49% Interest in Creo Medical SL Disposal agreed
THIS ANNOUNCEMENT WAS DEEMED BY THE COMPANY TO CONTAIN INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO.
RNS 9581352 ↗ -
07 May 26MicroBlate™ Fine commercial update
Creo Medical accelerates US clinical adoption and commercial rollout of MicroBlate Fine
RNS 9556008 ↗ -
05 May 26SpydrBlade™ Flex used in novel BEAM procedures
Creo Medical's SpydrBlade™ Flex used in novel bariatric endoscopic technique
RNS 9551036 ↗ -
30 Apr 26KOL presentations on Creo Core Products at DDW
KOL presentations on Creo Core Products at DDW
RNS 9545372 ↗ -
29 Apr 26UK private hospital use Speedboat for cancer case
First UK private hospital use Speedboat for colorectal cancer case
RNS 9542941 ↗ -
22 Apr 26Positive Q1 trading update
Strong trading momentum continues with 60% year-on-year revenue growth in Q1
RNS 9531506 ↗ -
16 Apr 26Disposal and outsourcing of manufacturing Disposal agreed
Sale of manufacturing business to further reduce operating costs and improve margins
RNS 9522683 ↗ -
24 Feb 26Appointment of Joint Corporate Broker
Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, announces the appointment of Shore Capital Stockbrokers Limited ("Shore Capital") as...
RNS 9443510 ↗ -
20 Jan 26
-
14 Jan 26Award of Shares under Share Incentive Plan
Award of Shares under Share Incentive Plan and Director Dealings
RNS 9351740 ↗ -
27 Oct 25Notice of Capital Markets Day
Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, announces that, further to the announcement on 7 October 2025, the Company will be...
RNS 9194961 ↗ -
07 Oct 25Capital Markets Day update
CMD to be rearranged to allow clinician case using Creo products to be completed
RNS 9155761 ↗
Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.